The PI3K/AKT pathway is overexpressed in ovarian and other common cancers, contributing to chemotherapy resistance, and inhibition of AKT sensitizes chemoresistant cells to cisplatin-induced apoptosis [52]. The gene discussed is AKT1; the disease is cancer.